Gabelli Funds’s SpringWorks Therapeutics SWTX Stock Holding History

Gabelli Funds’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-683,201	Closed	-$32.1M	–	1300
2025 Q2	$32.1M	Buy	683,201 +643,141	+1,605%	+$28.6M	0.23%	106
2025 Q1	$1.77M	Buy	+40,060	New	+$1.84M	0.01%	679

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's SWTX Position: Q3 2025 in Review

Gabelli Funds sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 683,201 shares — an estimated $32.1M sold.

Gabelli Funds first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $32.1M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Gabelli Funds reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Gabelli Funds sold 683,201 SpringWorks Therapeutics shares in Q3 2025, an estimated $32.1M.
Gabelli Funds first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Gabelli Funds's SpringWorks Therapeutics position peaked at $32.1M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.